Država: Belgija
Jezik: angleščina
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Measles virus (live, attenuated) ; Mumps virus (live, attenuated) ; Rubella virus (live, attenuated) ; Varicella-zoster virus (live, attenuated)
GlaxoSmithKline Biologicals SA-NV
J07BD54
Measles Virus; Mumps virus; Rubella Virus; Varicella Virus
Powder and solvent for solution for injection
Measles Virus; Mumps virus; Rubella Virus; Varicella Virus
Intramuscular use; Subcutaneous use
Measles, Combinations with Mumps, Rubella and Varicella, Live Attenuated
CTI code: 303852-01 - Pack size: 1 dose + 2 x Injection needle + 0.5 ml - Commercialisation status: NO - FMD code: 05400571001058 - CNK code: 2469567 - Delivery mode: Medical prescription; CTI code: 303852-03 - Pack size: 1 dose + 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 303852-02 - Pack size: 10 x 1 dose + 10 x 0.5 ml + 20 x Injection needle - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 303852-05 - Pack size: 20 x 1 dose + 20 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 303852-04 - Pack size: 10 x 1 dose + 10 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 303852-06 - Pack size: 50 x 1 dose + 50 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription
Commercialised: No
2007-10-08